DELIVER Subanalysis ' Seals Deal ' for Dapagliflozin in HF DELIVER Subanalysis ' Seals Deal ' for Dapagliflozin in HF

An analysis of the large global DELIVER trial found that dapagliflozin improved outcomes and symptoms across a wide range of patients with heart failure.MDedge News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Cardiology News Source Type: news